AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma.
Respiratory Care · 2025-05-01 · Guideline / consensus
Abstract
To address the lack of guidance for clinicians in their care of children with critical asthma, a multidisciplinary team of medical providers used Grading of Recommendations, Assessment, Development, and Evaluation methodology to make the following recommendations: 1. We suggest the use of continuous inhaled short-acting β agonist (SABA) over frequent intermittent SABA in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 2. We suggest the use of either high- or low-dose continuous inhaled SABA regimens in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 3. We suggest the use of either dexamethasone or methylprednisolone (or an equivalent dose of prednisone/prednisolone) for children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 4. We suggest the use of intravenous (IV) magnesium (intermittent or continuous) as an adjunct therapy in children treated for critical asthma. (Conditional recommendation, low certainty of evidence) 5. We cannot recommend for or against the use of IV methylxanthines as an adjunct therapy in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 6. We suggest the use of an IV SABA infusion as an adjunct therapy in children treated for critical asthma. (Conditional recommendation, low certainty of evidence) 7. We cannot recommend for or against the application of high-flow nasal cannula versus conventional oxygen therapy in children presenting with critical asthma with persistent hypoxemia and/or respiratory distress. (Conditional recommendation, very low certainty of evidence) 8. We suggest the use of bi-level positive airway pressure over conventional oxygen therapy in children presenting with critical asthma with persistent hypoxemia and/or respiratory distress. (Conditional recommendation, very low certainty of evidence) 9. We cannot recommend for or against the application of bi-level positive airway pressure over high-flow nasal cannula for children hospitalized with critical asthma with persistent hypoxemia and/or respiratory distress. (Conditional recommendation, very low certainty of evidence) 10. We cannot recommend for or against the application of heliox in children treated for critical asthma. (Conditional recommendation, very low certainty of evidence) 11. We suggest the use of a dedicated protocol or pathway for managing children treated for critical asthma. (Conditional recommendation, low certainty of evidence).
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
High-flow nasal oxygen · CPAP & NIV · Respiratory drugs · Corticosteroids · Children · Other drugs · Magnesium
Related articles
- Prehospital management of pediatric asthma patients in a large emergency medical services system. (Pediatr Pulmonol, 2020)
- Asthma and other recurrent wheezing disorders in children (acute). (BMJ Clin Evid, 2012)
- A Loading Dose of IV Salbutamol in an Adolescent with Severe Acute Asthma and Cardiac Arrest. (Case Rep Pediatr, 2019)
- The association of prehospital systemic corticosteroids with emergency department and in-hospital outcomes for patients with asthma exacerbations. (Acad Emerg Med, 2024)
- Intravenous Bronchodilators in Pediatric Critical Asthma: A Systematic Review and Network Meta-Analysis. (Pediatr Pulmonol, 2025)
- Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics. (Ital J Pediatr, 2018)